Uterine carcinosarcoma (malignant mixed Mullerian tumor - MMMT) is a high-grade aggressive uterine malignancy containing both epithelial (carcinoma) and mesenchymal (sarcoma) components. It accounts for 2-5% of all uterine malignancies but has a disproportionately high mortality rate. It typically presents in postmenopausal women (mean age 65-70). Tamoxifen use and prior pelvic radiation are known risk factors. Disease has usually spread beyond the uterus at diagnosis. Imaging characteristically shows a large, heterogeneous, polypoid endometrial mass with areas of necrosis. Prognosis is poor with 5-year survival around 30-40%.
Age Range
55-80
Peak Age
65
Gender
Female predominant
Prevalence
Rare
Carcinosarcoma is now accepted as a monoclonal tumor — originating from a single epithelial progenitor cell with mesenchymal differentiation (metaplasia). Hence the term 'metaplastic carcinoma' is also used. The carcinomatous component is most commonly high-grade serous or endometrioid histology. The sarcomatous component may contain homologous (leiomyosarcoma, endometrial stromal sarcoma) or heterologous (rhabdomyosarcoma, chondrosarcoma, osteosarcoma) elements. Presence of heterologous elements is associated with worse prognosis. The biphasic nature of the tumor produces marked heterogeneity on imaging — the carcinoma component appears as enhancing solid areas while the sarcoma component manifests as necrosis and hemorrhage zones. Rapid growth and early myometrial/extrauterine spread are imaging reflections of aggressive biology. Necrotic areas result from the tumor outgrowing its oxygen supply and appear as T2 hyperintense zones without diffusion restriction on MRI.
The hallmark finding of carcinosarcoma is a large, heterogeneous polypoid mass filling the endometrial cavity and extending toward or prolapsing through the cervical canal. This appearance results from the tumor's rapid growth rate and polypoid morphology. The heterogeneous composition — coexistence of solid, necrotic and hemorrhagic components — is characteristic of the biphasic tumor (carcinoma+sarcoma) and is a distinguishing finding from benign polyps or type I endometrial carcinoma.
Large, markedly heterogeneous polypoid endometrial mass on T2-weighted images. Solid components show intermediate signal intensity while necrotic areas demonstrate high signal intensity. The tumor typically fills the entire endometrial cavity and extends toward the cervical canal. Heterogeneous T2 signal reflects the biphasic tumor composition (carcinoma+sarcoma) and necrosis.
Report Sentence
Large polypoid mass filling the endometrial cavity, showing markedly heterogeneous signal on T2-weighted images with areas of necrosis.
Marked diffusion restriction in solid tumoral components on diffusion-weighted imaging (DWI) — hyperintense signal on high b-value images and low signal on ADC maps. Necrotic areas do not show diffusion restriction and produce high signal on ADC. This contrast is valuable in distinguishing viable tumor tissue from necrosis. ADC values in solid components are typically measured as <1.0 x 10^-3 mm2/s.
Report Sentence
Marked diffusion restriction is observed in solid components of the mass consistent with high cellularity; no diffusion restriction is noted in necrotic areas.
Marked heterogeneous enhancement in solid tumoral components on contrast-enhanced MRI — characteristic 'mosaic' pattern with lack of enhancement in necrotic areas. Enhancing solid areas represent viable tumor tissue while non-enhancing areas represent coagulative necrosis. Peripheral enhancement may increase in delayed phase. Myometrial invasion boundary is better assessed on contrast-enhanced sequences.
Report Sentence
Marked heterogeneous enhancement in solid components of the mass on contrast-enhanced MRI with extensive non-enhancing necrotic areas; mosaic pattern consistent with aggressive malignancy.
Large polypoid mass filling the endometrial cavity with heterogeneous echogenicity on transvaginal US. Solid components appear hypoechoic-isoechoic while necrotic/cystic areas appear anechoic-hypoechoic. Marked distension of the endometrial cavity and signs of myometrial invasion may accompany. US as first-line imaging reveals the diagnostic suspicion but MRI is needed for characterization.
Report Sentence
Large polypoid mass filling the endometrial cavity with heterogeneous echogenicity containing necrotic/cystic areas; consistent with aggressive endometrial malignancy.
Irregular, chaotic vascular pattern in solid tumoral components on Doppler US — increased vascularity with low resistance index (RI <0.4) arterial flow. Vascularity is decreased or absent in necrotic areas. Irregular branching pattern of tumor vessels reflects neovascularization. Feeding vessels originate from uterine arteries.
Report Sentence
Irregular vascular pattern with low resistance index arterial flow in solid components of the mass on Doppler US, consistent with malignant neovascularization.
Large, heterogeneously enhancing mass filling the uterine cavity on contrast-enhanced CT. Solid components show moderate enhancement while necrotic areas remain hypodense. Increased uterine size, disruption of myometrial contour, and signs of parametrial spread are observed. Pelvic and para-aortic lymph node enlargement may accompany. Abdominopelvic CT is valuable for peritoneal carcinomatosis and distant metastasis assessment.
Report Sentence
Large heterogeneously enhancing mass filling the uterine cavity with extensive necrotic areas on contrast-enhanced CT, consistent with aggressive uterine malignancy.
Focal high signal areas within the mass on T1-weighted images — representing hemorrhagic foci. Solid components appear isointense or slightly hypointense to muscle. Necrotic areas show low signal on T1. Hemorrhagic foci result from bleeding from fragile neovascular vessels within the tumor and acute-subacute hemorrhages appear T1 hyperintense (methemoglobin effect).
Report Sentence
Focal hyperintense areas within the mass on T1-weighted images, consistent with hemorrhagic foci.
Criteria
Sarcomatous component consists of mesenchymal tissue types normally found in uterus — leiomyosarcoma, endometrial stromal sarcoma, or fibrosarcoma. More common subtype. Does not show distinctive imaging features compared to heterologous type.
Distinct Features
Sarcoma component from uterine-native tissues, better prognosis than heterologous type, no specific distinguishing imaging feature
Criteria
Sarcomatous component consists of mesenchymal tissue types not normally found in uterus — rhabdomyosarcoma (most common), chondrosarcoma, or osteosarcoma. Presence of heterologous elements is associated with worse prognosis. Calcification or bone formation may be an imaging clue.
Distinct Features
Rhabdomyosarcoma/chondrosarcoma/osteosarcoma elements, calcification/ossification may be seen, worse prognosis, calcified foci on CT may be clue
Criteria
Polypoid tumor has prolapsed through the cervix into the vagina. This appearance is more characteristic of carcinosarcoma than other uterine sarcomas. The prolapsing mass may show a necrotic surface. Clinical examination reveals mass protrusion from the cervix.
Distinct Features
Polypoid mass prolapsing through cervix, necrotic surface, clinically visible, typical for carcinosarcoma
Distinguishing Feature
Leiomyosarcoma typically originates from myometrium and presents as an intramural mass, while carcinosarcoma originates from the endometrial cavity forming a polypoid mass. Leiomyosarcoma is a homogeneous sarcoma while carcinosarcoma has biphasic composition. Leiomyosarcoma shows less necrosis and has lower tendency to prolapse through cervix.
Distinguishing Feature
Type II (serous) endometrial carcinoma is generally smaller and more homogeneous in appearance. Carcinosarcoma is notably larger and more heterogeneous with extensive necrosis areas. However, definitive distinction without biopsy is difficult as both tumors show aggressive biology.
Distinguishing Feature
Endometrial stromal sarcoma is generally a slower-growing, homogeneous tumor showing worm-like myometrial infiltration and venous invasion. Carcinosarcoma is a rapidly growing polypoid, heterogeneous tumor with extensive necrosis. Stromal sarcoma shows diffuse hypointense muscle infiltration on T2 while carcinosarcoma shows prominent heterogeneity and necrosis.
Distinguishing Feature
Endometrial polyp is generally smaller, homogeneous and well-defined showing diffuse homogeneous enhancement on contrast MRI. Carcinosarcoma is a large, heterogeneous polypoid mass with necrosis. Polyp shows hyperintense fibrous core on T2 while carcinosarcoma shows heterogeneous signal mixed with necrosis/hemorrhage.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralCarcinosarcoma is a high-grade aggressive malignancy requiring urgent multidisciplinary evaluation. Standard treatment is total abdominal hysterectomy, bilateral salpingo-oophorectomy, and pelvic/para-aortic lymphadenectomy. Adjuvant chemotherapy (ifosfamide/paclitaxel or carboplatin/paclitaxel) and/or radiation therapy is administered. Prognosis is poor with recurrence rate of 50-60% even in stage I. FIGO staging is the most important prognostic factor. Peritoneal cytology, omental biopsy, and peritoneal survey are part of staging surgery.
Carcinosarcoma is one of the most aggressive uterine malignancies. 5-year survival is 30-35%. Surgical staging and complete debulking is the primary treatment. Adjuvant chemotherapy + radiotherapy is frequently administered. Peritoneal spread is common. Staged like endometrial carcinoma (FIGO 2009).